Contract Research Organizations (CROs) play a pivotal role in the drug discovery and development process, acting as essential partners for pharmaceutical and biotech companies. Over ...
For life sciences companies, which include software and services for the medical device, pharmaceutical manufacturers, and biotechnology firms, the challenge lies not just in promoting ...
The Life Sciences and Investment Banking sector is defined by rapid technological advancements and regulatory complexities, driving the need for specialized financial expertise. As 2024 ...
Introduction to Fairness Opinions In the complex world of corporate transactions, fairness opinions serve as an essential tool to ensure that all parties involved receive ...
The biotech and life sciences industry is experiencing a continuing rebound in 2024. After an overall market slowdown in investments and acquisitions, late Q4 2023 ...
Your pharmaceutical services company will likely attract significant attention from acquisition firms and larger pharma companies trying to expand their markets, customers, technology, and products. ...
In this Contract Research Organization (CRO) M&A Industry Update, we explore the M&A activity and projections for this sector within the Business Services industry. Within this ...
In this CRO Report, we provide tailwinds driving growth in the industry, an industry analysis, public comparables and precedent transactions, active buyers in the market, ...
Managing Director and regular PharmaBoardroom contributor David H. Crean. Ph.D looks at how the ongoing global coronavirus (COVID-19) outbreak has impacted the global economy, ...
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings".
Read our cookie policy